Association of sex and atrial fibrillation therapies with patient-reported outcomes
Open Access
Abstract
Objectives Women report higher atrial fibrillation (AF) symptom severity and receive less AF therapies than their male counterparts. It is understudied if differences in AF therapies received explains sex differences in AF symptom severity. We investigate the impact of sex and AF therapies on patient-reported outcomes. Methods Participants were recruited (n=953) across four academic medical centres with an AF diagnosis and age ≥18 years. Patient-reported outcomes (AF symptom severity, AF-related quality of life, functional status and emotional status) were determined by biannual surveys. We performed multiple linear regressions on propensity-matched cohorts to determine the association of AF therapies and sex on patient-reported outcomes. Results Our study population (n=953) was 65% male (n=616), 93% white (n=890) and 72 (±10) years old. Individuals receiving rate control therapy reported comparatively lower AF-related quality of life (−7.22, 95% CI −11.51 to –2.92) and poorer functional status (−3.69, 95% CI −5.27 to –2.12). Individuals receiving rhythm control strategies did not report significantly different patient-reported outcomes. Women were more likely to report poorer functional status (−2.63, 95% CI −3.86 to –1.40) and poorer AF-related quality of life, higher anxiety (2.33, 95% CI 1.07 to 3.59), higher symptoms of depression (1.48, 95% CI 0.31 to 2.65) and AF symptom severity (0.29, 95% CI 0.07 to 0.52). Conclusions Female sex was associated with comparatively poorer AF symptom severity and quality of life, and this association remained after accounting for AF therapies received. Receiving rate control medication alone was associated with comparatively poorer AF-related quality of life and functional status.Keywords
Funding Information
- National Center for Advancing Translational Sciences
- Patient-Centered Outcomes Research Institute
This publication has 29 references indexed in Scilit:
- Prospective Assessment of Short‐ and Long‐Term Quality of Life After Ablation for Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2011
- Long-term results of atrial fibrillation ablation: The importance of all initial ablation failures undergoing a repeat ablationAmerican Heart Journal, 2011
- Item Banks for Measuring Emotional Distress From the Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, Anxiety, and AngerAssessment, 2011
- Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2011
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008Journal of Clinical Epidemiology, 2010
- Gender-related differences in catheter ablation of atrial fibrillationEP Europace, 2007
- Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) studyAmerican Heart Journal, 2006
- Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial FibrillationJACC, 2005
- Combining Propensity Score Matching with Additional Adjustments for Prognostic CovariatesJournal of the American Statistical Association, 2000
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992